You are here

  • Home
  • Archive
  • Volume 8, Issue 1
  • CAR T-cell therapy for a relapsed/refractory acute B-cell lymphoblastic lymphoma patient in the context of Li-Fraumeni syndrome

Article metrics

Article menu

Download PDFPDF

XML
Case report
CAR T-cell therapy for a relapsed/refractory acute B-cell lymphoblastic lymphoma patient in the context of Li-Fraumeni syndrome

 

Online download statistics by month:

Online download statistics by month: April 2020 to March 2024

AbstractFullPdf
Apr 202011311450
May 2020292292231
Jun 202019319343
Jul 2020919161
Aug 2020494837
Sep 2020747437
Oct 2020424231
Nov 2020494917
Dec 2020585817
Jan 2021737331
Feb 2021838359
Mar 2021656529
Apr 2021656521
May 2021616137
Jun 2021434324
Jul 2021686881
Aug 2021383873
Sep 2021474747
Oct 2021636359
Nov 2021474730
Dec 2021494927
Jan 2022404210
Feb 2022424319
Mar 2022687026
Apr 2022818226
May 2022636322
Jun 2022757928
Jul 2022636417
Aug 2022949422
Sep 2022767935
Oct 2022535329
Nov 2022586231
Dec 2022414115
Jan 2023373712
Feb 2023828217
Mar 2023525415
Apr 2023222216
May 2023393912
Jun 2023212111
Jul 2023292910
Aug 2023232311
Sep 2023555515
Oct 2023676712
Nov 2023454510
Dec 2023595912
Jan 2024333418
Feb 2024565614
Mar 2024393953
Total307630971560